[1]
A. Nesen, K. Savicheva, P. Semenovykh, and V. Galchiskaya, “Vasopressin marker copeptin and the development of renal and metabolic disorders in patients with type 2 diabetes”, Ukr. J. Nephrol. Dial., no. 3(75), pp. 55-62, Jun. 2022.